Advertisement

Predictors of actinic keratosis count in patients with multiple keratinocyte carcinomas: A cross-sectional study

  • Julia A. Siegel
    Correspondence
    Correspondence to: Julia A. Siegel, BA, Center for Dermatoepidemiology, Department of Veterans Affairs Medical Center, 830 Chalkstone Ave, Providence, RI 02908-4799
    Affiliations
    Center for Dermatoepidemiology, Department of Veterans Affairs Medical Center, Providence, Rhode Island
    Search for articles by this author
  • Adam J. Luber
    Affiliations
    Department of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island
    Search for articles by this author
  • Martin A. Weinstock
    Affiliations
    Center for Dermatoepidemiology, Department of Veterans Affairs Medical Center, Providence, Rhode Island
    Search for articles by this author
  • for theDepartment of Veterans Affairs Topical Tretinoin Chemoprevention Trial and Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Groups
      To the Editor: Actinic keratoses (AKs) are common, are costly, and have the potential for malignant transformation to keratinocyte carcinoma (KC),

      Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. http://dx.doi.org/10.1111/bjd.14852. Published online August 8, 2016.

      ie, cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). We sought to determine predictors of AK in patients with a history of multiple KCs, as AKs are more likely to progress to KC in this high-risk population.

      Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. http://dx.doi.org/10.1111/bjd.14852. Published online August 8, 2016.

      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. http://dx.doi.org/10.1111/bjd.14852. Published online August 8, 2016.

        • Pomerantz H.
        • Hogan D.
        • Eilers D.
        • et al.
        Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial.
        JAMA Dermatol. 2015; 151: 952-960
        • Weinstock M.A.
        • Bingham S.F.
        • Digiovanna J.J.
        • et al.
        Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a Veterans Affairs randomized chemoprevention trial.
        J Invest Dermatol. 2012; 132: 1583-1590
        • Flohil S.C.
        • van der Leest R.J.T.
        • Dowlatshahi E.A.
        • Hofman A.
        • de Vries E.
        • Nijsten T.
        Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam study.
        J Invest Dermatol. 2013; 133: 1971-1978
        • Chen G.J.
        • Feldman S.R.
        • Williford P.M.
        • et al.
        Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer.
        Dermatol Surg. 2005; 31: 43-47